IIM
JBIO

INTECH Investment Management’s Jade Biosciences JBIO Stock Holding History

INTECH Investment Management’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,802
Closed -$182K – 2115
2025
Q4 		$182K Sell
11,802
-2,320
-16% -$27.2K ﹤0.01% 2017
2025
Q3 		$122K Sell
14,122
-8,873
-39% -$72.5K ﹤0.01% 2210
2025
Q2 		$230K Buy
+22,995
New +$783K ﹤0.01% 2019

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM

INTECH Investment Management's JBIO Position: Q1 2026 in Review

INTECH Investment Management sold out of Jade Biosciences (JBIO) in Q1 2026, closing a stake of 11,802 shares — an estimated $182K sold.

INTECH Investment Management first reported a position in JBIO in Q2 2025 and held it in 3 quarters. The position peaked at $230K in Q2 2025. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • INTECH Investment Management reported no remaining Jade Biosciences position as of Q1 2026 after selling out during the quarter.
  • INTECH Investment Management sold 11,802 Jade Biosciences shares in Q1 2026, an estimated $182K.
  • INTECH Investment Management first reported a position in Jade Biosciences in Q2 2025 and held it in 3 quarters.
  • INTECH Investment Management's Jade Biosciences position peaked at $230K in Q2 2025.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.